Want to track FOLD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Amicus Therapeutics, Inc. (FOLD) Statistics
Valuation metrics
Market Cap 4.55B
Enterprise value 4.7B
Trailing P/E (ttm) -
Forward P/E 15.09
PEG ratio 15.09
Price/Sales (ttm) 7.17
Price/Book (mrq) 16.43
Enterprise Value/Revenue 7.41
Enterprise Value/EBITDA 112
Overview
Shares outstanding 310.85M
Float 311.44M
Shares short 21.92M
% Held by insiders 0.01%
% Held by institutions 1.04%
Average volume (10 days) 2.89M
Average volume (90 days) 3.18M
Price summary
52-Week low 5.51
52-Week high 14.5
Beta 0.48
50-Day moving average 14.4
200-Day moving average 10.88
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -0.04%
Operating margin 0.09%
Operational effectiveness
Return on assets 0.02%
Return on equity -0.12%
Income Statement
Revenue (ttm) 634.21M
Revenue per share (ttm) 2.06
Quarterly revenue growth (yoy) 0.24%
Gross profit (ttm) 561.28M
EBITDA 55.51M
Net income to common (ttm) -27.11M
Diluted EPS (ttm) -0.09
Quarterly earnings growth (yoy) -0.89%
Balance Sheet
Total cash (mrq) 293.54M
Total cash per share (mrq) 0.94
Total debt (mrq) 442.36M
Total Debt/Equity (mrq) 161.3
Current ratio (mrq) 2.84%
Book value per share (mrq) 0.88
Cash Flow
Cash flow statement 33.15M
Levered free cash flow (LFCF) 47.84M
